Results 181 to 190 of about 6,509 (213)
Some of the next articles are maybe not open access.
Neurobiology of Learning and Memory, 2017
Experimental evidence indicates that the neurosteroids dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulphate (DHEAS) are involved in cognition. BNN27 is a novel 17C spiroepoxy-DHEA derivative, which devoid of steroidogenic activity. The neuroprotective effects of BNN27 have been recently reported.
Nikolaos, Pitsikas, Achille, Gravanis
openaire +2 more sources
Experimental evidence indicates that the neurosteroids dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulphate (DHEAS) are involved in cognition. BNN27 is a novel 17C spiroepoxy-DHEA derivative, which devoid of steroidogenic activity. The neuroprotective effects of BNN27 have been recently reported.
Nikolaos, Pitsikas, Achille, Gravanis
openaire +2 more sources
Journal of Ethnopharmacology
Dihuang Drink (DHD), formulated by Liu Hejian during the Yuan Dynasty, is listed as one of the first ancient classical prescriptions by the National Medical Products Administration of China. It is commonly used for the prevention and treatment of Alzheimer's disease (AD).
Wenna Su +5 more
openaire +2 more sources
Dihuang Drink (DHD), formulated by Liu Hejian during the Yuan Dynasty, is listed as one of the first ancient classical prescriptions by the National Medical Products Administration of China. It is commonly used for the prevention and treatment of Alzheimer's disease (AD).
Wenna Su +5 more
openaire +2 more sources
ACS Chemical Neuroscience, 2018
On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compound 2 has proven this method was feasible in AD ...
Wei Ni +10 more
openaire +2 more sources
On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compound 2 has proven this method was feasible in AD ...
Wei Ni +10 more
openaire +2 more sources
Neurotoxicity Research
Aminopyrimidine compounds have been gaining traction in the field of drug discovery in recent years due to their emergence as multi-targeted molecules. This makes them perfect candidates as agents for cognitive improvement, as cognitive decline is a multifaceted condition.
Behnaz, Landi +6 more
openaire +2 more sources
Aminopyrimidine compounds have been gaining traction in the field of drug discovery in recent years due to their emergence as multi-targeted molecules. This makes them perfect candidates as agents for cognitive improvement, as cognitive decline is a multifaceted condition.
Behnaz, Landi +6 more
openaire +2 more sources
Synthesis and evaluation of enzyme inhibitory potential of some derivatives of scopolamine
Turkish Journal of Chemistry, 2012TANIA KHAN +2 more
openaire +1 more source
Epidural scopolamine derivative injection in patients with chronic pain
Pain, 1990openaire +1 more source
Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer’s Disease
CNS and Neurological Disorders - Drug Targets, 2020Win Ning Chen, Keng Yoon Yeong
exaly
Proceedings of the Virtual 2020 AOCS Annual Meeting & Expo, 2020
Shigeru Katayama, Soichiro Nakamura
openaire +1 more source
Shigeru Katayama, Soichiro Nakamura
openaire +1 more source